Gene amplification refers to a genomic change that results in an increased dosage of the gene(s) affected. Amplification represents one of the major molecular pathways through which the oncogenic potential of proto-oncogenes is activated during tumorigenesis. The architecture of amplified genomic st
Assessing sequential oncogene amplification in human breast cancer
✍ Scribed by Laura E. Janocko; Joseph F. Lucke; David W. Groft; Kathryn A. Brown; Charles A. Smith; Agnese A. Pollice; Sarita G. Singh; Robert Yakulis; Robert J. Hartsock; Stanley E. Shackney
- Book ID
- 102816025
- Publisher
- John Wiley and Sons
- Year
- 1995
- Tongue
- English
- Weight
- 534 KB
- Volume
- 21
- Category
- Article
- ISSN
- 0196-4763
No coin nor oath required. For personal study only.
✦ Synopsis
Abstract
Studies of amplification and/or overexpression of c‐myc, HER‐2/neu, and H‐ras in breast cancer have shown that each is associated with a poor prognosis. The purpose of this study was to explore the possibility that there is a preferred sequence of amplification of these oncogenes in breast cancer. The frequencies of amplification and patterns of co‐amplification of c‐myc, HER‐2/neu, and H‐ras were studied in a group of 84 breast cancers. The data suggested a preferred sequence of amplification that consisted of c‐myc amplification‐HER‐2/neu amplification‐H‐ras amplification. This model was supported by loglinear analysis. In addition, the levels of amplification of JC‐A, a DNA fragment newly isolated from a patient with advanced breast cancer, were studied in 61 of these cases. The data suggested that JC‐A amplification occurred early. Loglinear analysis supported a model in which JC‐A amplification occurred either before or after c‐myc amplification but was unrelated to Her‐2/neu or ras amplification. © 1995 Wiley‐Liss, Inc.
📜 SIMILAR VOLUMES
Alterations in the gene copy numbers of the proto-oncogenes HERZ/neu and c-myc in primary human breast cancer investigated in 73 patients. We detected amplification of H€R2/ neu in 17 patient samples and amplification of c-myc in I I, while amplification of both was seen in 6 samples. There was no c
## Abstract As the prognostic significance of the three most frequently amplified oncogenes in breast cancer (__c‐myc, int‐2IFGF3__, and c‐__erbB‐2lnew__) is still unclear, and as the amplification of these genes appears to be mutually exclusive, we investigated the prognostic significance of oncog
Cytogenetic studies on fresh human breast cancers revealed that homogeneously staining regions (HSRs), which are assumed t o represent DNA amplification, are observed in almost half of the cases. To search for a possible relationship between HSRs and proto-oncogene amplification, I 6 proto-oncogenes